Numbers & Facts
More than 37%
of patients received a research-based diagnosis for the first time through CADS (as of July 2023)
More than 3800
Patients are registered in the phenyotypisation software SAMS (as of July 2023)
of patients received a research-based diagnosis for the first time through CADS (as of July 2023)
Patients are registered in the phenyotypisation software SAMS (as of July 2023)